242 related articles for article (PubMed ID: 23429005)
1. A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan.
Habib M; Soofi S; Ali N; Sutter RW; Palansch M; Qureshi H; Akhtar T; Molodecky NA; Okayasu H; Bhutta ZA
Vaccine; 2013 Apr; 31(15):1987-93. PubMed ID: 23429005
[TBL] [Abstract][Full Text] [Related]
2. A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people.
Kim HJ; Hwang S; Lee S; Kwon Y; Park K; Park YJ; Bae GR; Lee SW; Jeong YS; Hyeon JY
BMC Infect Dis; 2015 Mar; 15():164. PubMed ID: 25881203
[TBL] [Abstract][Full Text] [Related]
3. Poliovirus neutralizing antibody levels among individuals in three regions of Ghana.
Opare JK; Akweongo P; Afari EA; Odoom JK
Ghana Med J; 2019 Jun; 53(2):170-180. PubMed ID: 31481814
[TBL] [Abstract][Full Text] [Related]
4. Survey of poliovirus antibodies during the final stage of polio eradication in Egypt.
El-Sayed N; Al-Jorf S; Hennessey KA; Salama M; Watkins MA; Abdelwahab JA; Pallansch MA; Gary H; Wahdan MH; Sutter RW
Vaccine; 2007 Jun; 25(27):5062-70. PubMed ID: 17543428
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan.
Saleem AF; Mach O; Quadri F; Khan A; Bhatti Z; Rehman NU; Zaidi S; Weldon WC; Oberste SM; Salama M; Sutter RW; Zaidi AK
Vaccine; 2015 Jun; 33(24):2757-63. PubMed ID: 25917673
[TBL] [Abstract][Full Text] [Related]
6. Poliovirus immunity among pregnant females aged 15-44 years, Namibia, 2010.
Cardemil CV; Jonas A; Gerber S; Weldon WC; Oberste MS; Beukes A; Sawadogo S; Patel SV; Zeko S; Muroua C; Gaeb E; Wannemuehler K; Goodson JL
J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S136-42. PubMed ID: 25316828
[TBL] [Abstract][Full Text] [Related]
7. Zinc supplementation fails to increase the immunogenicity of oral poliovirus vaccine: a randomized controlled trial.
Habib MA; Soofi S; Sheraz A; Bhatti ZS; Okayasu H; Zaidi SZ; Molodecky NA; Pallansch MA; Sutter RW; Bhutta ZA
Vaccine; 2015 Feb; 33(6):819-25. PubMed ID: 25500307
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of vaccine derived poliovirus type 2 outbreak response options: A randomized controlled trial, Karachi, Pakistan.
Saleem AF; Yousafzai MT; Mach O; Khan A; Quadri F; Weldon WC; Oberste MS; Zaidi SS; Alam MM; Sutter RW; Zaidi AKM
Vaccine; 2018 Mar; 36(13):1766-1771. PubMed ID: 29477307
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015-2016.
Hussain I; Mach O; Habib A; Bhatti Z; Suhag Z; Oberste MS; Weldon WC; Sutter RW; Soofi SB; Bhutta ZA
Pediatr Infect Dis J; 2017 Sep; 36(9):e230-e236. PubMed ID: 28806355
[TBL] [Abstract][Full Text] [Related]
10. Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies.
Pan WK; Seidman JC; Ali A; Hoest C; Mason C; Mondal D; Knobler SL; Bessong P;
Vaccine; 2019 Jan; 37(2):352-365. PubMed ID: 30442479
[TBL] [Abstract][Full Text] [Related]
11. Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine.
Hendry AJ; Beard FH; Dey A; Quinn H; Hueston L; Dwyer DE; McIntyre PB
Vaccine; 2020 Mar; 38(11):2572-2577. PubMed ID: 32037225
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of poliovirus antibodies in Nigeria: refining strategies to sustain the eradication effort.
Bolu O; Adamu U; Franka R; Umeokonkwo CD; An Q; Greby S; McDonald S; Mainou B; Mba N; Agala N; Archer WR; Braka F; Etapelong SG; Gashu TS; Siddique AR; Asekun A; Okoye M; Iriemenam N; Wiesen E; Swaminathan M; Ihekweazu C; Shuaib F
Pan Afr Med J; 2023; 45(Suppl 2):2. PubMed ID: 38370104
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of poliovirus antibodies among 7-month-old infants after 4 doses of oral polio vaccine in Sistan-va-Baluchestan, Islamic Republic of Iran.
Izadi S; Shahmahmoodi S; Zahraei SM; Dorostkar F; Majdzadeh SR
East Mediterr Health J; 2015 Apr; 21(2):83-9. PubMed ID: 25876819
[TBL] [Abstract][Full Text] [Related]
14. Assessment of poliovirus antibody seroprevalence in polio high risk areas of West Africa.
Guindo O; Mach O; Doumbia S; Ekra DK; Beavogui AH; Weldon WC; Oberste MS; Sutter RW
Vaccine; 2018 Feb; 36(8):1027-1031. PubMed ID: 29358054
[TBL] [Abstract][Full Text] [Related]
15. Assessment of seroprevalence against poliovirus among Italian adolescents and adults.
Lupi S; Stefanati A; Baldovin T; Roman A; Baldo V; Gabutti G
Hum Vaccin Immunother; 2019; 15(3):677-682. PubMed ID: 30427738
[TBL] [Abstract][Full Text] [Related]
16. Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010.
Khetsuriani N; Pallansch MA; Jabirov S; Saparova N; Oberste MS; Wannemuehler K; Ursu P; Wassilak S; Martin R
Vaccine; 2013 Oct; 31(42):4911-6. PubMed ID: 23891502
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of Different Routine Poliovirus Vaccination Schedules: A Randomized, Controlled Trial in Karachi, Pakistan.
Saleem AF; Mach O; Yousafzai MT; Khan A; Weldon WC; Steven Oberste M; Zaidi SS; Alam MM; Quadri F; Sutter RW; Zaidi AKM
J Infect Dis; 2018 Jan; 217(3):443-450. PubMed ID: 29126173
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological serosurvey of poliovirus in Guangdong, China: A cross-sectional study.
Tan Q; Zhu Q; Zheng H; Zhang B; Wu C; Guo X; Li H; Liu L; Liu Y; Rutherford S; Zheng H
Hum Vaccin Immunother; 2018; 14(11):2644-2648. PubMed ID: 30059644
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017.
Hussain I; Mach O; Hamid NA; Bhatti ZS; Moore DD; Oberste MS; Khan S; Khan H; Weldon WC; Sutter RW; Bhutta ZA; Soofi SB
Vaccine; 2018 Apr; 36(15):1921-1924. PubMed ID: 29510918
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of Poliomyelitis Antibodies Among Children Aged 1 to 4 Years Old and Factors Associated With Poliovirus Susceptibility; Mexican Health and Nutrition Survey, 2012.
Díaz-Quiñónez JA; Díaz-Ortega JL; Cruz-Hervert P; Ferreira-Guerrero E; Delgado-Sánchez G; Ferreyra-Reyes L; López-Martínez I; Torres-Longoria B; Aparicio-Antonio R; Montero-Campos R; Mongua-Rodríguez N; Garcia-Garcia L
Clin Infect Dis; 2018 Oct; 67(suppl_1):S110-S114. PubMed ID: 30376082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
